Development of a Fission Yeast-Based High-Throughput Screen to Identify Chemical Regulators of cAMP Phosphodiesterases

Abstract

Cyclic nucleotide phosphodiesterases (PDEs) comprise a superfamily of enzymes that serve as drug targets in many human diseases. There is a continuing need to identify high-specificity inhibitors that affect individual PDE families or even subtypes within a single family. The authors describe a fission yeast-based high-throughput screen to detect inhibitors of heterologously expressed adenosine 3′,5′-cyclic monophosphate (cAMP) PDEs. The utility of this system is demonstrated by the construction and characterization of strains that express mammalian PDE2A, PDE4A, PDE4B, and PDE8A and respond appropriately to known PDE2A and PDE4 inhibitors. High-throughput screens of 2 bioactive compound libraries for PDE inhibitors using strains expressing PDE2A, PDE4A, PDE4B, and the yeast PDE Cgs2 identified known PDE inhibitors and members of compound classes associated with PDE inhibition. The authors verified that the furanocoumarin imperatorin is a PDE4 inhibitor based on its ability to produce a PDE4-specific elevation of cAMP levels. This platform can be used to identify PDE activators, as well as genes encoding PDE regulators, which could serve as targets for future drug screens. (Journal of Biomolecular Screening 2008:62-71)

Keywords

Schizosaccharomyces pombe cAMP phosphodiesterase high throughput inhibitors

References

Kamenetsky M. , Middelhaufe S. , Bank EM , Levin LR , Buck J. , Steegborn C. : Molecular details of cAMP generation in mammalian cells: a tale of two systems. J Mol Biol 2006 ;362(4):623-639.

Bender AT , Beavo JA : Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use . Pharmacol Rev 2006;58(3):488-520.

Lerner A. , Epstein PM : Cyclic nucleotide phosphodiesterases as targets for treatment of haematological malignancies. Biochem J 2006;393(pt 1):21-41.

Vasta V. , Shimizu-Albergine M. , Beavo JA : Modulation of Leydig cell function by cyclic nucleotide phosphodiesterase 8A. Proc Natl Acad Sci U S A 2006;103:19925-19930.

Dyke HJ , Montana JG : Update on the therapeutic potential of PDE4 inhibitors. Expert Opin Investig Drugs 2002;11(1):1-13.

Boswell-Smith V. , Spina D. , Page CP : Phosphodiesterase inhibitors . Br J Pharmacol 2006;147(suppl 1):S252-S257.

O'Donnell JM , Zhang HT : Antidepressant effects of inhibitors of cAMP phosphodiesterase (PDE4). Trends Pharmacol Sci 2004;25(3):158-163.

Lugnier C. : Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents. Pharmacol Ther 2006;109(3):366-398.

Hebb AL , Robertson HA : Role of phosphodiesterases in neurological and psychiatric disease . Curr Opin Pharmacol 2007;7(1):86-92.

10.

Hoffman CS , Winston F. : Isolation and characterization of mutants constitutive for expression of the fbp1 gene of Schizosaccharomyces pombe. Genetics 1990;124(4):807-816.

11.

Hoffman CS : Glucose sensing via the protein kinase A pathway in Schizosaccharomyces pombe . Biochem Soc Trans 2005;33(pt 1):257-260.

12.

Hoffman CS : Except in every detail: comparing and contrasting G protein signaling in Saccharomyces cerevisiae and Schizosaccharomyces pombe. Eukaryotic Cell 2005;4:495-503.

13.

Degols G. , Shiozaki K. , Russell P. : Activation and regulation of the Spc1 stress-activated protein kinase in Schizosaccharomyces pombe. Mol Cell Biol 1996;16(6):2870-2877.

14.

Stettler S. , Warbrick E. , Prochnik S. , Mackie S. , Fantes P. : The wis1 signal transduction pathway is required for expression of cAMP- repressed genes in fission yeast. J Cell Sci 1996;109(pt 7):1927-1935.

15.

Stiefel J. , Wang L. , Kelly DA , Janoo RTK , Seitz J. , Whitehall SK , et al: Suppressors of an adenylate cyclase deletion in the fission yeast Schizosaccharomyces pombe. Eukaryotic Cell 2004;3(3):610-619.

16.

Wang L. , Griffiths K. , Zhang YH , Ivey FD , Hoffman CS : Schizosaccharomyces pombe adenylate cyclase suppressor mutations suggest a role for cAMP phosphodiesterase regulation in feedback control of glucose/cAMP signaling. Genetics 2005;171:1523-1533.

17.

Mochizuki N. , Yamamoto M. : Reduction in the intracellular cAMP level triggers initiation of sexual development in fission yeast. Mol Gen Genet 1992;233(1-2):17-24.

18.

Kim YK , Arai MA , Arai T. , Lamenzo JO , Dean EF III , Patterson N. , et al: Relationship of stereochemical and skeletal diversity of small molecules to cellular measurement space. J Am Chem Soc 2004;126(45):14740-14745.

19.

Franz AK , Dreyfuss PD , Schreiber SL : Synthesis and cellular profiling of diverse organosilicon small molecules . J Am Chem Soc 2007;129(5):1020-1021.

20.

Cherry JA , Thompson BE , Pho V. : Diazepam and rolipram differentially inhibit cyclic AMP-specific phosphodiesterases PDE4A1 and PDE4B3 in the mouse. Biochim Biophys Acta 2001;1518(1-2):27-35.

21.

Soderling SH , Bayuga SJ , Beavo JA : Cloning and characterization of a cAMP-specific cyclic nucleotide phosphodiesterase. Proc Natl Acad Sci U S A 1998;95(15):8991-8996.

22.

Wu AY , Tang XB , Martinez SE , Ikeda K. , Beavo JA : Molecular determinants for cyclic nucleotide binding to the regulatory domains of phosphodiesterase 2A. J Biol Chem 2004;279(36):37928-37938.

23.

DeVoti J. , Seydoux G. , Beach D. , McLeod M. : Interaction between ran1+ protein kinase and cAMP dependent protein kinase as negative regulators of fission yeast meiosis. EMBO J 1991;10(12):3759-3768.

24.

Ivey FD , Hoffman CS Direct activation of fission yeast adenylate cyclase by the Gpa2 Gα of the glucose signaling pathway. Proc Natl Acad Sci U S A 2005;102(17):6108-6113.

25.

Nocero M. , Isshiki T. , Yamamoto M. , Hoffman CS : Glucose repression of fbp1 transcription of Schizosaccharomyces pombe is partially regulated by adenylate cyclase activation by a G protein α subunit encoded by gpa2 (git8). Genetics 1994 ;138(1):39-45.

26.

Welton RM , Hoffman CS : Glucose monitoring in fission yeast via the gpa2 Gα, the git5 Gβ, and the git3 putative glucose receptor. Genetics 2000;156:513-521.

27.

Toone WM , Kuge S. , Samuels M. , Morgan BA , Toda T. , Jones N. : Regulation of the fission yeast transcription factor Pap1 by oxidative stress: requirement for the nuclear export factor Crm1 (Exportin) and the stress-activated MAP kinase Sty1/Spc1. Genes Dev 1998;12(10):1453-1463.

28.

Toda T. , Shimanuki M. , Yanagida M. : Fission yeast genes that confer resistance to staurosporine encode an AP-1-like transcription factor and a protein kinase related to the mammalian ERK1/MAP2 and budding yeast FUS3 and KSS1 kinases. Genes Dev 1991;5(1):60-73.

29.

Zhang JH , Chung TD , Oldenburg KR : A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 1999;4(2):67-73.

30.

Colicelli J. , Nicolette C. , Birchmeier C. , Rodgers L. , Riggs M. , Wigler M. : Expression of three mammalian cDNAs that interfere with RAS function in Saccharomyces cerevisiae . Proc Natl Acad Sci U S A 1991;88(7):2913-2917.

31.

Pillai R. , Kytle K. , Reyes A. , Colicelli J. : Use of a yeast expression system for the isolation and analysis of drug-resistant mutants of a mammalian phosphodiesterase. Proc Natl Acad Sci U S A 1993;90(24):11970-11974.

32.

Atienza JM , Colicelli J. : Yeast model system for study of mammalian phosphodiesterases. Methods 1998;14(1):35-42.

33.

Wachtel H. : Characteristic behavioural alterations in rats induced by rolipram and other selective adenosine cyclic 3′, 5′-monophosphate phosphodiesterase inhibitors. Psychopharmacology (Berl) 1982;77(4):309-316.

34.

Wachtel H. : Potential antidepressant activity of rolipram and other selective cyclic adenosine 3′,5′-monophosphate phosphodiesterase inhibitors . Neuropharmacology 1983;22(3):267-272.

35.

Lamontagne S. , Meadows E. , Luk P. , Normandin D. , Muise E. , Boulet L. , et al: Localization of phosphodiesterase-4 isoforms in the medulla and nodose ganglion of the squirrel monkey. Brain Res 2001;920(1-2):84-96.

36.

Miro X. , Perez-Torres S. , Puigdomenech P. , Palacios JM , Mengod G. : Differential distribution of PDE4D splice variant mRNAs in rat brain suggests association with specific pathways and presynaptical localization . Synapse 2002;45(4):259-269.

37.

Peluso MR : Flavonoids attenuate cardiovascular disease, inhibit phosphodiesterase, and modulate lipid homeostasis in adipose tissue and liver. Exp Biol Med (Maywood) 2006;231(8):1287-1299.

38.

Duarte J. , Lugnier C. , Torres AI , Perez-Vizcaino F. , Zarzuelo A. , Tamargo J. : Effects of visnagin on cyclic nucleotide phosphodiesterases and their role in its inhibitory effects on vascular smooth muscle contraction. Gen Pharmacol 1999;32(1):71-74.

39.

Bovalini L. , Lusini P. , Simoni S. , Vedaldi D. , Andreassi L. , Dall'Acqua F. , et al: Inhibition of cAMP phosphodiesterase by some phototherapeutic agents. Z Naturforsch C 1987;42(7-8):1009-1010.

40.

Sancho R. , Marquez N. , Gomez-Gonzalo M. , Calzado MA , Bettoni G. , Coiras MT , et al: Imperatorin inhibits HIV-1 replication through an Sp1-dependent pathway. J Biol Chem 2004;279(36):37349-37359.

41.

Angel JB , Saget BM , Walsh SP , Greten TF , Dinarello CA , Skolnik PR , et al: Rolipram, a specific type IV phosphodiesterase inhibitor, is a potent inhibitor of HIV-1 replication. AIDS 1995;9(10):1137-1144.